Christopher R. Seaton

Vorsitzender bei Middlesex Hospital

Health Services

Consumer Services

Health Technology

Profil

Christopher R.
Seaton is currently the Chairman at Middlesex Hospital and Director at Versantis AG.
He completed his undergraduate and MBA degrees from McMaster University.

Aktive Positionen von Christopher R. Seaton

Unternehmen	Position	Beginn
Middlesex Hospital Middlesex Hospital Hospital/Nursing ManagementHealth Services Middlesex Hospital, located in Middletown, CT, provides healthcare services to patients and families. The hospital prides itself on providing quality care and treating patients like family.	Vorsitzender	19.04.2010
Versantis AG Versantis AG BiotechnologyHealth Technology Versantis AG develops liver disease therapeutics and diagnostics. Its pipeline include VS-01, a drug to support liver, brain, and kidneys; VS-02 and VS-03 that are solutions for chronic liver diseases and treatment of drug intoxications; and other products for the treatment of metabolic academia and diagnosis of hyperammonemia. The company was founded by Vincent Forster and Meriam Kabbaj in 2015 and is headquartered in Zurich, Switzerland.	Direktor/Vorstandsmitglied	05.02.2021

Alle aktiven Positionen von Christopher R. Seaton

Ausbildung von Christopher R. Seaton

McMaster University

Masters Business Admin

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Christopher R. Seaton im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	2
Middlesex Hospital Middlesex Hospital Hospital/Nursing ManagementHealth Services Middlesex Hospital, located in Middletown, CT, provides healthcare services to patients and families. The hospital prides itself on providing quality care and treating patients like family.	Health Services
Versantis AG Versantis AG BiotechnologyHealth Technology Versantis AG develops liver disease therapeutics and diagnostics. Its pipeline include VS-01, a drug to support liver, brain, and kidneys; VS-02 and VS-03 that are solutions for chronic liver diseases and treatment of drug intoxications; and other products for the treatment of metabolic academia and diagnosis of hyperammonemia. The company was founded by Vincent Forster and Meriam Kabbaj in 2015 and is headquartered in Zurich, Switzerland.	Health Technology